unknown
Stage
2
Investors
About
ArmaGen Technologies develops biologic medicines that use novel antibody engineering and drug delivery technologies to extend the half-life and improve tissue targeting of therapeutics.
Explore ArmaGen Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.